神经科指南

订阅

MedSci主页 / 所有栏目 / 神经科指南

2021 MSTCG立场声明：多发性硬化的疾病修饰疗法

2021-08-18 多发性硬化治疗共识小组 Therapeutic Advances in Neurological Disorders

多发性硬化症

2021年8月，多发性硬化治疗共识小组(MSTCG)发布了多发性硬化的疾病修饰疗法建议，多发性硬化是一种复杂的、自身免疫介导的中枢神经系统疾病，其特征是炎症性脱髓鞘和轴突/神经元损伤。疾病修饰疗法改变

中文标题：

2021 MSTCG立场声明：多发性硬化的疾病修饰疗法

英文标题：

Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)

发布机构：

多发性硬化治疗共识小组

发布日期：

2021-08-18

简要介绍：

2021年8月，多发性硬化治疗共识小组(MSTCG)发布了多发性硬化的疾病修饰疗法建议，多发性硬化是一种复杂的、自身免疫介导的中枢神经系统疾病，其特征是炎症性脱髓鞘和轴突/神经元损伤。疾病修饰疗法改变了多发性硬化的预后和病程，本文主要针对多发性硬化的疾病修饰治疗提供最新的指导建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 MSTCG立场声明：多发性硬化的疾病修饰疗法.pdf)] GetToolGuiderByIdResponse(projectId=1, id=7f26d1c0022030f8, title=2021 MSTCG立场声明：多发性硬化的疾病修饰疗法, enTitle=Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper), guiderFrom=Therapeutic Advances in Neurological Disorders, authorId=0, author=, summary=2021年8月，多发性硬化治疗共识小组(MSTCG)发布了多发性硬化的疾病修饰疗法建议，多发性硬化是一种复杂的、自身免疫介导的中枢神经系统疾病，其特征是炎症性脱髓鞘和轴突/神经元损伤。疾病修饰疗法改变, cover=https://img.medsci.cn/20211012/1634019017551_5579292.jpg, journalId=0, articlesId=null, associationId=2003, associationName=多发性硬化治疗共识小组, associationIntro=多发性硬化治疗共识小组(MSTCG,Multiple Sclerosis Therapy Consensus Group), copyright=0, guiderPublishedTime=Wed Aug 18 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年8月，多发性硬化治疗共识小组(MSTCG)发布了多发性硬化的疾病修饰疗法建议，多发性硬化是一种复杂的、自身免疫介导的中枢神经系统疾病，其特征是炎症性脱髓鞘和轴突/神经元损伤。疾病修饰疗法改变了多发性硬化的预后和病程，本文主要针对多发性硬化的疾病修饰治疗提供最新的指导建议。</span></p>, tagList=[TagDto(tagId=972, tagName=多发性硬化症)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=3389, guiderKeyword=多发性硬化, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3650, appHits=166, showAppHits=0, pcHits=1366, showPcHits=3484, likes=0, shares=13, comments=7, approvalStatus=1, publishedTime=Tue Oct 12 14:13:50 CST 2021, publishedTimeString=2021-08-18, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Tue Oct 12 14:12:38 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Thu Jan 04 09:11:59 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 MSTCG立场声明：多发性硬化的疾病修饰疗法.pdf)])
2021 MSTCG立场声明：多发性硬化的疾病修饰疗法.pdf
下载请点击：
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1179427, encodeId=858711e942754, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fec24659817, createdName=1491450296, createdTime=Fri Dec 31 22:11:36 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071680, encodeId=d50610e16806a, content=<a href='/topic/show?id=2b71430987f' target=_blank style='color:#2F92EE;'>#多发性硬化#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43098, encryptionId=2b71430987f, topicName=多发性硬化)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Fri Nov 19 10:03:05 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067594, encodeId=9a54106e5949e, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85345637822, createdName=ms6000000207316158, createdTime=Sat Nov 06 15:22:30 CST 2021, time=2021-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066610, encodeId=64b51066610fc, content=想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/3efa3a98e8364620babed16f91f55dec/8a2f1a7d4adb489bbc2f0d62d8efea04.jpg, createdBy=ec5f1688529, createdName=医皛生, createdTime=Wed Nov 03 15:50:52 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065860, encodeId=700a106586076, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6efb2459695, createdName=124151c2m00暂无昵称, createdTime=Mon Nov 01 17:26:59 CST 2021, time=2021-11-01, status=1, ipAttribution=)]
    2021-12-31 1491450296

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1179427, encodeId=858711e942754, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fec24659817, createdName=1491450296, createdTime=Fri Dec 31 22:11:36 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071680, encodeId=d50610e16806a, content=<a href='/topic/show?id=2b71430987f' target=_blank style='color:#2F92EE;'>#多发性硬化#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43098, encryptionId=2b71430987f, topicName=多发性硬化)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Fri Nov 19 10:03:05 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067594, encodeId=9a54106e5949e, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85345637822, createdName=ms6000000207316158, createdTime=Sat Nov 06 15:22:30 CST 2021, time=2021-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066610, encodeId=64b51066610fc, content=想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/3efa3a98e8364620babed16f91f55dec/8a2f1a7d4adb489bbc2f0d62d8efea04.jpg, createdBy=ec5f1688529, createdName=医皛生, createdTime=Wed Nov 03 15:50:52 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065860, encodeId=700a106586076, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6efb2459695, createdName=124151c2m00暂无昵称, createdTime=Mon Nov 01 17:26:59 CST 2021, time=2021-11-01, status=1, ipAttribution=)]
    2021-11-19 病毒猎手

    #多发性硬化#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1179427, encodeId=858711e942754, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fec24659817, createdName=1491450296, createdTime=Fri Dec 31 22:11:36 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071680, encodeId=d50610e16806a, content=<a href='/topic/show?id=2b71430987f' target=_blank style='color:#2F92EE;'>#多发性硬化#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43098, encryptionId=2b71430987f, topicName=多发性硬化)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Fri Nov 19 10:03:05 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067594, encodeId=9a54106e5949e, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85345637822, createdName=ms6000000207316158, createdTime=Sat Nov 06 15:22:30 CST 2021, time=2021-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066610, encodeId=64b51066610fc, content=想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/3efa3a98e8364620babed16f91f55dec/8a2f1a7d4adb489bbc2f0d62d8efea04.jpg, createdBy=ec5f1688529, createdName=医皛生, createdTime=Wed Nov 03 15:50:52 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065860, encodeId=700a106586076, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6efb2459695, createdName=124151c2m00暂无昵称, createdTime=Mon Nov 01 17:26:59 CST 2021, time=2021-11-01, status=1, ipAttribution=)]
    2021-11-06 ms6000000207316158

    学习一下

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1179427, encodeId=858711e942754, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fec24659817, createdName=1491450296, createdTime=Fri Dec 31 22:11:36 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071680, encodeId=d50610e16806a, content=<a href='/topic/show?id=2b71430987f' target=_blank style='color:#2F92EE;'>#多发性硬化#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43098, encryptionId=2b71430987f, topicName=多发性硬化)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Fri Nov 19 10:03:05 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067594, encodeId=9a54106e5949e, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85345637822, createdName=ms6000000207316158, createdTime=Sat Nov 06 15:22:30 CST 2021, time=2021-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066610, encodeId=64b51066610fc, content=想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/3efa3a98e8364620babed16f91f55dec/8a2f1a7d4adb489bbc2f0d62d8efea04.jpg, createdBy=ec5f1688529, createdName=医皛生, createdTime=Wed Nov 03 15:50:52 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065860, encodeId=700a106586076, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6efb2459695, createdName=124151c2m00暂无昵称, createdTime=Mon Nov 01 17:26:59 CST 2021, time=2021-11-01, status=1, ipAttribution=)]
    2021-11-03 医皛生

    想学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1179427, encodeId=858711e942754, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fec24659817, createdName=1491450296, createdTime=Fri Dec 31 22:11:36 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071680, encodeId=d50610e16806a, content=<a href='/topic/show?id=2b71430987f' target=_blank style='color:#2F92EE;'>#多发性硬化#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43098, encryptionId=2b71430987f, topicName=多发性硬化)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Fri Nov 19 10:03:05 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067594, encodeId=9a54106e5949e, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85345637822, createdName=ms6000000207316158, createdTime=Sat Nov 06 15:22:30 CST 2021, time=2021-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066610, encodeId=64b51066610fc, content=想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/3efa3a98e8364620babed16f91f55dec/8a2f1a7d4adb489bbc2f0d62d8efea04.jpg, createdBy=ec5f1688529, createdName=医皛生, createdTime=Wed Nov 03 15:50:52 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065860, encodeId=700a106586076, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6efb2459695, createdName=124151c2m00暂无昵称, createdTime=Mon Nov 01 17:26:59 CST 2021, time=2021-11-01, status=1, ipAttribution=)]
    2021-11-01 124151c2m00暂无昵称

    学习

    0

相关指南

多发性硬化症治疗共识小组 (MSTCG)：对讨论问题的回答

多发性硬化症治疗共识小组 (MSTCG) · 2021-08-02

对符合免疫抑制治疗条件的多发性硬化症患者的疫苗接种建议：西班牙共识声明

暂未更新 · 2020-06-23

多发性硬化症患者的疾病调节药物和计划生育：海湾地区的共识

暂未更新 · 2020-06-23

2016 CMSC修订建议：标准化MRI协议和多发性硬化的诊断与随访

国际多发性硬化专家组(International Panel of MS) · 2016-03-01

拓展阅读

证据报告：米托蒽醌治疗多发性硬化中的安全性及有效性

美国神经病学学会(AAN,American Academy of Neurology) · 2010-01-01

中国多发性硬化诊断和治疗专家共识(2010)

中华医学会神经病学分会神经免疫学组 · 2010-01-01

多发性硬化诊断标准：McDonald标准2010修订版

美国神经病学学会(AAN,American Academy of Neurology) · 2010-11-29

多发性硬化诊断和治疗中国专家共识(2011版)

中华医学会神经病学分会神经免疫学组 · 2011-04-01

2013 亚太促进特发性脱髓鞘疾病（多发性硬化和视神经脊髓炎）患者早期治疗指南

亚太脱髓鞘疾病专家组（统称） · 2013-01-16

2013 美国神经病学会（AAN）多发性硬化精神障碍评估及管理指南

美国神经病学学会(AAN,American Academy of Neurology) · 2013-12-27